Topics
Glioblastoma | Treatment | Radiotherapy | Dose escalation
Home > Publications > Topics > Glioblastoma > Treatment > Radiotherapy > Dose escalation
Maier
SH, Schönecker S, Anagnostatou V, Garny S, Nitschmann A,
Fleischmann DF, Büttner M, Kaul D, Imhoff D, Fokas E, Seidel
C, Hau P, Kölbl O, Popp I, Grosu AL, Haussmann J, Budach W,
Celik E, Kahl KH, Hoffmann E, Tabatabai G, Paulsen F, Holzgreve A,
Albert NL, Mansmann U, Corradini S, Belka C, Niyazi M, Bodensohn
R.
Dummy
run for planning of isotoxic dose-escalated radiation therapy for
glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01;
AG-NRO-06).
Clin
Transl Radiat Oncol.
2024 May 4;47:100790. doi:
10.1016/j.ctro.2024.100790. PMID:
38765202. Observational study. ˍ
Haisraely O, Sivan M, Symon Z, Ben-Ayun M, Tsvang L, Kraitman J,
Dubinsky S, Siman-Tov M, Benjamin D, Lawrence Y, Cohen Z, Wohl A,
Kaisman-Elbaz T, Taliansky A.
Dose
escalation with simultaneous integrated boost for un-methylated
multiple glioblastoma.
Rep Pract Oncol Radiother. 2024 Jul 22;29(3):290-293.
doi:
10.5603/rpor.100385. PMID:
39144267. Observational
study. ˍ